Neonatal pulmonary care
Research activity includes premature infants with bronchopulmonary dysplasia, with interest in regenerative medicine and cell-based therapy for early-life lung disease.
- Mesenchymal stem cells
- Preterm neonatal respiratory disorders
- Bronchopulmonary dysplasia
The sponsor’s work in this area is centered on respiratory outcomes in very early gestation and the clinical management of chronic lung injury in newborns.
Infectious diseases and antimicrobial therapy
Clinical studies address HIV infection and intra-abdominal candidiasis, with attention to treatment effects in persistent viral infection and invasive fungal disease.
- HIV-1 latent reservoir
- Antiretroviral therapy
- Candidiasis
- Antifungal treatment
These trials connect virology, mycology, and clinical pharmacology in settings where infection control and tissue exposure are central concerns.
Thromboembolic and cardiopulmonary disease
Research includes acute pulmonary embolism, with focus on cardiopulmonary stabilization and recovery in patients at intermediate risk.
- Pulmonary embolism
- Oxygen therapy
- Cardiopulmonary outcomes
This area reflects interest in acute vascular obstruction and supportive respiratory treatment in hospital-based care.
Ophthalmology and pediatric myopia
Trials in myopia examine visual development in children and the progression of refractive error over time.
- Myopia progression
- Refractive status
- Pediatric eye health
The sponsor’s ophthalmic research is directed toward childhood vision disorders and management of progressive short-sightedness.
